eJIAS: The Journal of HIV/AIDS Science and Medicine in the Developing World
Notice bibliographique
Résumé
On behalf of the International AIDS Society (IAS), Medscape, and our editors, we are pleased to introduce eJIAS: eJournal of the International AIDS Society, a new peer-reviewed journal dedicated to the science and practice of HIV/AIDS medicine in the developing world. And, on the occasion of the largest international gathering of HIV/AIDS scientists and healthcare and public health workers in 2 years, we are privileged to present the official online abstracts of the XV International AIDS Conference (Bangkok, Thailand; July 11–16, 2004) in this inaugural issue of eJIAS. eJIAS http://www.eJIAS.org is an online, primary-source, peer-reviewed medical journal created to foster publication by researchers from developing countries and to enhance the accessibility and exchange of essential HIV/AIDS knowledge among frontline scientists, healthcare providers, and public health professionals working in diverse, but commonly resource-limited, settings. Copublished by IAS and Medscape, eJIAS is the first and only HIV/AIDS journal specifically for the publication of original, peer-reviewed articles that are highly relevant to the study, prevention, and treatment of HIV/AIDS in the developing world. In keeping with the theme of the XV International AIDS Conference, “Access for All,” eJIAS seeks to encourage and facilitate publication by scientists and clinicians working in developing countries, and to thereby improve the dissemination of high-quality medical evidence from research conducted in a diversity of geographic, cultural, socioeconomic, and clinical settings. The 2-fold objective of these efforts is to enhance the quality and exchange of vital frontline HIV/AIDS data and knowledge, and to enable scientists and healthcare personnel to remain informed about research, analysis, and opinion relevant to the delivery of HIV/AIDS prevention, treatment, and care in developing countries and on a global scale. eJIAS is available free of charge wherever there is a Web connection. To increase the accessibility and useful adoption of the journal, the contents of eJIAS are published in parallel, and indexed for MEDLINE, in Medscape General Medicine http://www.MedGenMed.com, Medscape's veteran, MEDLINE-indexed general-medicine journal. Through this unique collaborative approach and the combined membership, publishing, and program experience of IAS and Medscape, the research contributions and frontline perspectives published in eJIAS will reach more than 2 million healthcare professionals in 249 countries. We are grateful to the Bristol-Myers Squibb Foundation for making the creation and launch of eJIAS possible through a founding grant from their Secure the Future program. With this announcement, we dedicate eJIAS to our colleagues who are striving to change the course of AIDS around the world. It is our sincere hope that eJIAS will serve, creatively and consistently, to advance their best efforts and elevate the quality of research, information sharing, and education that must attend expanding global HIV/AIDS care initiatives. Mark A. Wainberg, PhD, has disclosed that he has received grants for clinical research from GlaxoSmithKline and Bristol-Myers Squibb. Joep M. A. Lange, MD, has disclosed that he has received grants for clinical research and/or honoraria for educational and/or advisory activities from Bristol-Myers Squibb, Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Idenix, Merck, and Roche. Helene D. Gayle, MD, has no significant financial interests or relationships to disclose. Craig McClure has no significant financial interests or relationships to disclose. Craig Sterritt has no significant financial interests or relationships to disclose.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction machine sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.
Scores du classifieur distillé par catégorie (deux têtes)
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,007 | 0,027 |
| Méta-épidémiologie (sens strict) | 0,001 | 0,001 |
| Méta-épidémiologie (sens large) | 0,002 | 0,001 |
| Bibliométrie | 0,006 | 0,008 |
| Études des sciences et des technologies | 0,002 | 0,003 |
| Communication savante | 0,017 | 0,005 |
| Science ouverte | 0,002 | 0,003 |
| Intégrité de la recherche | 0,003 | 0,008 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,035 | 0,020 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».